|
시장보고서
상품코드
2075158
중화항체 시장 : 항체 유형별, 표적 바이러스별, 최종 용도별, 유통 채널별, 지역별Neutralizing Antibody Market, By Antibody Type, By Target Virus, By End Use, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
중화항체 시장은 2026년에 2,654억 달러로 추정되고 있으며, 2033년까지 4,789억 6,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 8.8%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 2,654억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.80% | 2033년 시장 규모 예측 : | 4,789억 6,000만 달러 |
중화항체는 선천 면역의 중요한 구성 요소이며, 자연 감염과 백신 접종 모두를 통해 유도됩니다. 이러한 항체는 바이러스의 특정 부위를 인식하여, 바이러스가 세포에 결합하여 감염되는 것을 막습니다. 항체의 특수한 구조 덕분에 바이러스의 스파이크 단백질에 있는 수용체 결합 도메인(RBD)에 결합하여, 바이러스가 숙주세포의 수용체와 결합해 세포 내로 침입하는 것을 막습니다.
시장 역학:
전 세계 중화항체 시장은 예측 기간 중 급속한 성장이 예상됩니다. 이러한 성장의 주요 촉진요인 중 하나는 간염, HIV, 결핵 등의 감염병 유병률이 높다는 점입니다. 몇 가지 치료용 모노클로널 항체(mAb)가 이용 가능하다는 점도 시장 성장을 지원하는 요인 중 하나입니다. 또한 mAb 개발을 위한 첨단 기술의 도입도 이 시장의 성장을 촉진할 것으로 예상됩니다. 그러나 이러한 검사에 드는 비용이 높다는 점이 도입을 제한하고, 결과적으로 시장의 성장을 저해할 가능성이 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 중화항체 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 중화항체 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 중화항체 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 중화항체 시장 : 항체 유형별, 2021-2026년
제5장 중화항체 시장 : 표적 바이러스별, 2021-2026년
제6장 중화항체 시장 : 용도별, 2021-2026년
제7장 중화항체 시장 : 최종사용자별, 2021-2026년
제8장 중화항체 시장 : 유통 채널별, 2021-2026년
제9장 중화항체 시장 : 지역별, 2021-2026년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.07Neutralizing Antibody Market is estimated to be valued at USD 265.40 Bn in 2026 and is expected to reach USD 478.96 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 265.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 478.96 Bn |
Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.
Market Dynamics:
The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market
Neutralizing Antibody Market Detailed Segmentation:
- By Antibody Type (Revenue, USD Bn, 2021 - 2033):
- Monoclonal Antibodies
- Polyclonal Antibodies
- By Target Virus (Revenue, USD Bn, 2021 - 2033):
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
- By Application (Revenue, USD Bn, 2021 - 2033):
- Therapeutics
- Diagnostics
- Research and Development
- By End User (Revenue, USD Bn, 2021 - 2033):
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033):
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Neutralizing Antibody Market , By Antibody Type, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Bn)
5. Neutralizing Antibody Market , By Target Virus, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
6. Neutralizing Antibody Market , By Application, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
7. Neutralizing Antibody Market , By End User, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
8. Neutralizing Antibody Market , By Distribution Channel, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
9. Neutralizing Antibody Market , By Region, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
10. Competitive Landscape
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
